Company: INMB
Filing Date: 2025-03-27
Form Type: 8-K
Source: 0001013762-25-003401
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial statements and Exhibits

(d) Exhibits.

  99.1      Press Release, dated March 27, 2025                                          
 ─────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

                            INMUNE BIO INC.                               
  Date: March 27, 2025      By:                  /s/ David Moss           
                                                 David Moss               
                                                 Chief Financial Officer